Showing results (81-90 of 128) with videos related to
Sort By:
Pageof 13
Cell Reports|December 8, 2016
Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal TransitionValentine Comaills, Lilian Kabeche, Robert Morris, et al.Cell Reports|April 22, 2014
Isolation and molecular characterization of circulating melanoma cellsXi Luo, Devarati Mitra, Ryan J Sullivan, et al.Cancer Discovery|August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expressionJames P Sullivan, Brian V Nahed, Marissa W Madden, et al.NPJ Precision Oncology|July 26, 2019
Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancerArielle J Medford, Taronish D Dubash, Dejan Juric, et al.Science (New York, N.Y.)|February 2, 2013
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal compositionMin Yu, Aditya Bardia, Ben S Wittner, et al.Biorxiv : the Preprint Server for Biology|April 16, 2025
Epitope Expression Persists in Circulating Tumor Cells as Breast Cancers Acquire Resistance to Antibody Drug ConjugatesAvanish Mishra, Rachel Abelman, Quinn Cunneely, et al.Breast Cancer Research and Treatment|June 15, 2023
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cellsTaronish D Dubash, Aditya Bardia, Brian Chirn, et al.Science (New York, N.Y.)|July 12, 2014
Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibilityMin Yu, Aditya Bardia, Nicola Aceto, et al.Nature Communications|November 25, 2017
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cellsKeith H K Wong, Shannon N Tessier, David T Miyamoto, et al.Nature Communications|July 5, 2020
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug targetJoseph W Franses, Julia Philipp, Pavlos Missios, et al.Pageof 13